Clinical Trial Update: A Trial of Metformin in Individuals With Fragile X Syndrome [Phase 2, Phase 3]

View source ↗

Summary

The document reports the completion of a Phase 2/Phase 3 clinical trial evaluating metformin in individuals with Fragile X syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fragile Syndrome

Drugs mentioned

• metformin (metformin)

Snippet

Sponsor: University of California, Davis | Conditions: Fragile X Syndrome, Fragile X Mental Retardation Syndrome | Phase 2, Phase 3 | Status: COMPLETED